HER2 Evaluation and Its Impact on Breast Cancer Treatment Decisions
Author:
Publisher
S. Karger AG
Subject
Genetics(clinical),Public Health, Environmental and Occupational Health
Reference52 articles.
1. Cancer Statistics, 2007
2. Closing the Evidence Gap in the Use of Emerging Testing Technologies in Clinical Practice
3. Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene
4. HER-2 Testing in Breast Cancer Using Parallel Tissue-Based Methods
Cited by 48 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Performance and Clinical Applicability of HER2 Digital Image Analysis in Breast Cancer: A Systematic Review;Cancers;2024-08-03
2. Utility of Axillary Staging in Older Patients with HER2-Positive Breast Cancer;Annals of Surgical Oncology;2024-07-16
3. Intracranial management of HER-2 overexpression breast cancer with extensive volume or symptomatic brain metastases;Frontiers in Oncology;2024-07-01
4. The safety of trastuzumab deruxtecan (DS‐8201) with a focus on interstitial lung disease and/or pneumonitis: A systematic review and single‐arm meta‐analysis;Cancer;2024-05-04
5. Automated HER2 Scoring in Breast Cancer Images Using Deep Learning and Pyramid Sampling;BME Frontiers;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3